Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is the RLYB116, an inhibitor of complement component 5 (C5) to treat several ... Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is the RLYB116, an inhibitor of complement component 5 (C5) to treat several diseases of complement dysregulation which has completed phase 1 trial; and RLYB332, a preclinical antibody, for the treatment of severe anemia with ineffective erythropoiesis and iron overload. The company has a strategic alliance with AbCellera to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases, as well as collaboration agreement with Johnson & Johnson to provide therapeutic solutions for pregnant individuals at risk of fetal and neonatal alloimmune thrombocytopenia. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -0.313479623824 | 15.95 | 16.5 | 15.76 | 27426 | 15.92391645 | CS |
| 4 | 1.28 | 8.75512995896 | 14.62 | 17.5738 | 13.8 | 70720 | 15.90442823 | CS |
| 12 | 7.03 | 79.2559188275 | 8.87 | 17.5738 | 7.9 | 265931 | 13.58636988 | CS |
| 26 | 15.17 | 2078.08219178 | 0.73 | 17.5738 | 0.5592 | 233036 | 9.84937301 | CS |
| 52 | 15.5744 | 4783.29238329 | 0.3256 | 17.5738 | 0.3 | 909546 | 1.70156025 | CS |
| 156 | 8.13 | 104.633204633 | 7.77 | 17.5738 | 0.2201 | 510914 | 2.00348432 | CS |
| 260 | 0.98 | 6.56836461126 | 14.92 | 25.78 | 0.2201 | 347992 | 2.82442296 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。